As part of the model-fitting process, we also estimated the BRCA1 and BRCA2 breast and ovarian cancer risks, but these were based on a relatively small number of mutation-carrying families and were therefore imprecise (Antoniou et al, 2002, 2004). Here, BRCA2 is linked to ovarian carcinoma.